These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 20175768)
1. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768 [TBL] [Abstract][Full Text] [Related]
2. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075 [TBL] [Abstract][Full Text] [Related]
3. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Vannella L; Sbrozzi-Vanni A; Lahner E; Bordi C; Pilozzi E; Corleto VD; Osborn JF; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2011 Jun; 33(12):1361-9. PubMed ID: 21492197 [TBL] [Abstract][Full Text] [Related]
4. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687 [TBL] [Abstract][Full Text] [Related]
5. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568 [TBL] [Abstract][Full Text] [Related]
6. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk. Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683 [TBL] [Abstract][Full Text] [Related]
7. The gastric mucosa in gastric cancer patients in a low-incidence area. Genta RM; Pusztaszeri M Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1085-93. PubMed ID: 16957515 [TBL] [Abstract][Full Text] [Related]
8. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas. Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824 [TBL] [Abstract][Full Text] [Related]
9. [Gastric mucosal lesions and their transition rates in high risk population of gastric cancer]. You WC Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):100-2. PubMed ID: 1879285 [TBL] [Abstract][Full Text] [Related]
10. Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. Rugge M; Baffa R; Farinati F; Di Mario F; Guido M; Valiante F; Ninfo V Ital J Gastroenterol; 1991 Feb; 23(2):70-3. PubMed ID: 1747506 [TBL] [Abstract][Full Text] [Related]
11. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa]. Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262 [TBL] [Abstract][Full Text] [Related]
12. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis? Lahner E; Corleto VD; D'Ambra G; Di Giulio E; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2008 Feb; 27(4):355-65. PubMed ID: 18047563 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073 [TBL] [Abstract][Full Text] [Related]
14. [Gastroscopy in follow-up studies of patients with chronic atrophic gastritis and diagnosis of early gastric cancer]. Sokolov LK; Nikiforov PA; Vasil'ev ID; Gul'kevich KIu; Sklianskaia OA; Iarushnikov KIu Klin Med (Mosk); 1990 Nov; 68(11):108-11. PubMed ID: 2283796 [TBL] [Abstract][Full Text] [Related]
15. [Non-specific chronic gastritis and gastric dysplasia, what is their clinical values?]. Martínez Alcalá F; Rivera Hueto F; Galera Davidson H; Martínez Pérez F Rev Esp Enferm Apar Dig; 1989 Dec; 76(6 Pt 1):545-50. PubMed ID: 2623309 [TBL] [Abstract][Full Text] [Related]
16. [Risk findings of the gastric mucosa--a clinicopathologic discussion]. Heilmann KL; Lux G Leber Magen Darm; 1985 Jan; 15(1):1-12. PubMed ID: 3974395 [TBL] [Abstract][Full Text] [Related]
17. Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up. Di Giulio E; Lahner E; Micheletti A; Milione M; D'Ambra G; Bordi C; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2005 Mar; 21(5):567-74. PubMed ID: 15740540 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Lahner E; Bordi C; Cattaruzza MS; Iannoni C; Milione M; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2005 Sep; 22(5):471-81. PubMed ID: 16128686 [TBL] [Abstract][Full Text] [Related]
19. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801 [TBL] [Abstract][Full Text] [Related]
20. A topographic analysis of atrophic gastritis and stomach cancer risk. A clinicoepidemiological study in Poland. Jedrychowski W; Popiela T; Steindorf K; Matyja A; Gryglewski A; Nowak K; Kieltyka A; Wahrendorf J; Becher H Cent Eur J Public Health; 1997 Sep; 5(3):117-21. PubMed ID: 9386896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]